BackChina SXT Pharmaceuticals Overview

China SXT Pharmaceuticals Operating Income

Operating Income for SXTC.

Quarterly Operating Income

$-1021106.00
↓ 129.88% YoY

As of Mar 31, 2025

Annual Operating Income (TTM)

$-2680480.00
↓ 62.72% YoY

Trailing 12 months ending Mar 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin